Exact Mass: 779.4009

Exact Mass Matches: 779.4009

Found 25 metabolites which its exact mass value is equals to given mass value 779.4009, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cyclosomatostatin

6-(4-aminobutyl)-12-benzyl-3-[1-(benzyloxy)ethyl]-9-[(1H-indol-3-yl)methyl]-1,4,7,10,13-pentaazacycloicosane-2,5,8,11,14-pentone

C44H57N7O6 (779.437)

Toporoside D

N-((26-O-beta-D-glucuronopyranosyl)-11,16-dioxo-2S-methoxy-5Z-hexacosenoyl)-dopamine

C41H65NO13 (779.4456)

Xanthylium,3,6-bis(diethylamino)-9-[2-[[[9-(diethylamino)-5H-benzo[a]phenoxazin-5-ylidene]amino]carbonyl]phenyl]-,chloride (1:1)

C48H50ClN5O3 (779.3602)

Ktxfw

C44H57N7O6 (779.437)

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells[1].

Demycosaminyl-nystatin

C41H63O14- (779.4218)

(2S)-2-[[(2E,4E,6E,11R)-12-[(4S,4aS,6R,8S,8aR)-4-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-hydroxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-6-yl]-11-hydroxydodeca-2,4,6-trienoyl]amino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(2E,4E,6E,11R)-12-[(4S,4aS,6R,8S,8aR)-4-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-hydroxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-6-yl]-11-hydroxydodeca-2,4,6-trienoyl]amino]-5-(diaminomethylideneamino)pentanoic acid

C38H61N5O12 (779.4317)

Digoxin anion

C41H63O14- (779.4218)

digoxin(1-)

C41H63O14 (779.4218)

An organic anion that is the conjugate base of digoxin resulting from the deprotonation of furanone moiety; major species at pH 7.3.

PC 22:5/11:3;O3

C41H66NO11P (779.4373)

PC 33:8;O3

C41H66NO11P (779.4373)

LNAPS 35:7;O

C41H66NO11P (779.4373)

PS 22:4/13:3;O

C41H66NO11P (779.4373)

PS 22:5/12:3;O2

C40H62NO12P (779.4009)

PS 22:6/11:3;O3

C39H58NO13P (779.3646)

PS 22:6/12:2;O2

C40H62NO12P (779.4009)

PS 33:9;O3

C39H58NO13P (779.3646)

PS 34:8;O2

C40H62NO12P (779.4009)

PS 35:7;O

C41H66NO11P (779.4373)

SHexCer 35:8;O2

C41H65NO11S (779.4278)

(15z,17z,19z,21z,23z)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,29-tetrahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

(15z,17z,19z,21z,23z)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,29-tetrahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

C40H61NO14 (779.4092)

(2s)-2-{[(2e,4e,6e,11r)-12-[(4s,4as,6r,8s,8ar)-4-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-hydroxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}-8-methoxy-7,7-dimethyl-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]-1,11-dihydroxydodeca-2,4,6-trien-1-ylidene]amino}-5-carbamimidamidopentanoic acid

(2s)-2-{[(2e,4e,6e,11r)-12-[(4s,4as,6r,8s,8ar)-4-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-hydroxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}-8-methoxy-7,7-dimethyl-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]-1,11-dihydroxydodeca-2,4,6-trien-1-ylidene]amino}-5-carbamimidamidopentanoic acid

C38H61N5O12 (779.4317)

(15z,17z,19z,21e,23z)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,29-tetrahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

(15z,17z,19z,21e,23z)-25-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,9,29-tetrahydroxy-7,11-dioxo-13-(sec-butyl)-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

C40H61NO14 (779.4092)